5 Best Biotech Penny Stocks To Buy Now
NuCana plc (NASDAQ:NCNA) is a British biotech firm which develops drug therapies to treat various forms of cancer.
Minerva Neurosciences Inc. (NERV)
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 1,024,000 | $850 | 0.01% | |
| 2. | Millennium Management Israel Englander | 788,077 | $654 | -2% | 0% |
| 3. | Renaissance Technologies Jim Simons | 389,952 | $324 | -35% | 0% |
| 4. | D E Shaw D. E. Shaw | 91,355 | $76 | -9% | 0% |
| 5. | 45,300 | $38 | -37% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.97 | 7,000 | Director | 20,333 | 2020-09-10 | Filing | |
| $5.50 | 3,500 | Director | 26,111 | 2019-06-27 | Filing | |
| $5.37 | 10,000 | Director | 13,333 | 2019-06-26 | Filing | |
| $5.25 | 1,000 | Director | 1,000 | 2019-06-26 | Filing | |
| $5.60 | 10,000 | Director | 10,000 | 2019-06-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.88 | 55,635 | Director | 163,553 | 2021-12-01 | Filing | |
| $2.64 | 3,228 | Officer | 31,747 | 2020-12-16 | Filing | |
| $2.64 | 6,190 | Officer | 211,354 | 2020-12-16 | Filing | |
| $2.64 | 1,300 | Officer, Director | 66,490 | 2020-12-16 | Filing | |
| $2.64 | 1,845 | Officer | 10,039 | 2020-12-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 9,610,200 | $7,976 | 0.01% | |
| 2. | 3,936,640 | $3,268 | 0% | |
| 3. | 1,768,685 | $1,465 | 0% | |
| 4. | 533 | $442 | 0% | |
| 5. | 501,876 | $417 | 0% |
News See All
5 Penny Stocks with Upcoming Growth Catalysts
Osceola Gold, Inc. (OTC:OSCI) is a precious metals mining company that is primarily focused on the exploration of gold. The company is based in Weirton, West Virginia.
Is NERV A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Hedge Fund Sentiment Is Stagnant On Minerva Neurosciences, Inc (NERV)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Buying Minerva Neurosciences, Inc (NERV)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Minerva Neurosciences, Inc (NERV): Are Hedge Funds Right About This Stock?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Is Minerva Neurosciences, Inc (NERV) A Good Stock To Buy?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Hedge Funds Aren’t Crazy About Minerva Neurosciences Inc (NERV) Anymore
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...
Baker Bros. Opened Positions In These 5 Healthcare Stocks
Julian Baker and Felix Baker founded Baker Bros. Advisors in 2000.
Here’s Why We’re Excited About The Upcoming Minerva Neurosciences Inc (NERV) Data
Minerva Neurosciences Inc (NASDAQ:NERV) just served up an update as to the progress of its two lead programs, and the company has remained relatively flat on the insight.
Billionaire Hedge Funds
